AMOREPACIFIC CORPORATION
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- -
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2015-09-14
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 74
- Registration Number
- NCT02052531
- Locations
- π°π·
Kyu-Han Kim, Seoul, Korea, Republic of
Cumulative Irritation Test of PAC-14028 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Other: SalineOther: PAC14028-VehicleDrug: PAC14028-0.1Drug: PAC14028-0.3Drug: PAC14028-1.0Other: Positive
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 35
- Registration Number
- NCT01638117
- Locations
- π°π·
Seoul National University Hospital, Department of Dermatology, Seoul, Korea, Republic of
PAC-14028 in Healthy Male Volunteers
- First Posted Date
- 2010-12-21
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT01264224
- Locations
- π°π·
Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath